» Articles » PMID: 25742692

A Facile Method to Establish Human Induced Pluripotent Stem Cells from Adult Blood Cells Under Feeder-free and Xeno-free Culture Conditions: a Clinically Compliant Approach

Overview
Date 2015 Mar 7
PMID 25742692
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Reprogramming human adult blood mononuclear cells (MNCs) cells by transient plasmid expression is becoming increasingly popular as an attractive method for generating induced pluripotent stem (iPS) cells without the genomic alteration caused by genome-inserting vectors. However, its efficiency is relatively low with adult MNCs compared with cord blood MNCs and other fetal cells and is highly variable among different adult individuals. We report highly efficient iPS cell derivation under clinically compliant conditions via three major improvements. First, we revised a combination of three EBNA1/OriP episomal vectors expressing five transgenes, which increased reprogramming efficiency by ≥10-50-fold from our previous vectors. Second, human recombinant vitronectin proteins were used as cell culture substrates, alleviating the need for feeder cells or animal-sourced proteins. Finally, we eliminated the previously critical step of manually picking individual iPS cell clones by pooling newly emerged iPS cell colonies. Pooled cultures were then purified based on the presence of the TRA-1-60 pluripotency surface antigen, resulting in the ability to rapidly expand iPS cells for subsequent applications. These new improvements permit a consistent and reliable method to generate human iPS cells with minimal clonal variations from blood MNCs, including previously difficult samples such as those from patients with paroxysmal nocturnal hemoglobinuria. In addition, this method of efficiently generating iPS cells under feeder-free and xeno-free conditions allows for the establishment of clinically compliant iPS cell lines for future therapeutic applications.

Citing Articles

Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs).

Manganelli M, Mazzoldi E, Ferraro R, Pinelli M, Parigi M, Aghel S Stem Cell Rev Rep. 2024; 20(8):2303-2317.

PMID: 39168923 PMC: 11554879. DOI: 10.1007/s12015-024-10776-6.


iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer's disease.

Zivko C, Sagar R, Xydia A, Lopez-Montes A, Mintzer J, Rosenberg P Mol Psychiatry. 2024; 29(11):3644-3652.

PMID: 38840027 PMC: 11541203. DOI: 10.1038/s41380-024-02629-y.


Polygenic risk for schizophrenia converges on alternative polyadenylation as molecular mechanism underlying synaptic impairment.

Raabe F, Hausruckinger A, Gagliardi M, Ahmad R, Almeida V, Galinski S bioRxiv. 2024; .

PMID: 38260577 PMC: 10802452. DOI: 10.1101/2024.01.09.574815.


CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells.

Hammad R, Alzubi J, Rhiel M, Chmielewski K, Mosti L, Rositzka J Int J Mol Sci. 2024; 25(2).

PMID: 38256061 PMC: 10816062. DOI: 10.3390/ijms25020985.


Avian iPSC Derivation to Recover Threatened Wild Species: A Comprehensive Review in Light of Well-Established Protocols.

Nogueira I, Costa G, Lacerda S Animals (Basel). 2024; 14(2).

PMID: 38254390 PMC: 10812705. DOI: 10.3390/ani14020220.


References
1.
Merling R, Sweeney C, Choi U, de Ravin S, Myers T, Otaizo-Carrasquero F . Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood. 2013; 121(14):e98-107. PMC: 3617640. DOI: 10.1182/blood-2012-03-420273. View

2.
Mali P, Ye Z, Chou B, Yen J, Cheng L . An improved method for generating and identifying human induced pluripotent stem cells. Methods Mol Biol. 2010; 636:191-205. DOI: 10.1007/978-1-60761-691-7_12. View

3.
Liang G, Zhang Y . Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell. 2013; 13(2):149-59. PMC: 3760008. DOI: 10.1016/j.stem.2013.07.001. View

4.
Cheng L, Hansen N, Zhao L, Du Y, Zou C, Donovan F . Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell. 2012; 10(3):337-44. PMC: 3298448. DOI: 10.1016/j.stem.2012.01.005. View

5.
Chou B, Mali P, Huang X, Ye Z, Dowey S, Resar L . Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011; 21(3):518-29. PMC: 3193421. DOI: 10.1038/cr.2011.12. View